43857-0173 NDC - TREE ANTIGEN (AMERICAN BEECH, AMERICAN ELM, BLACK WALNUT, BLACK WILLOW, NEGUNDO, EASTERN COTTONWOOD, HICKORY, RED BIRCH, RED OAK, PLATANUS, FRAXINUS AMERICANA, MELALEUCA BLOSSOM, ARSENICUM ALBUM, LYCOPODIUM CLAVATUM, PULSATILLA VULGARIS)

Drug Information

Product NDC: 43857-0173

Proprietary Name: TREE ANTIGEN

Non Proprietary Name: American Beech, American Elm, Black Walnut, Black Willow, Negundo, Eastern Cottonwood, Hickory, Red Birch, Red Oak, Platanus, Fraxinus Americana, Melaleuca Blossom, Arsenicum Album, Lycopodium Clavatum, Pulsatilla Vulgaris

Active Ingredient(s):
  • 6 [hp_X]/mL ACER NEGUNDO POLLEN;
  • 12 [hp_X]/mL ARSENIC TRIOXIDE;
  • 6 [hp_X]/mL BETULA OCCIDENTALIS POLLEN;
  • 6 [hp_X]/mL CARYA OVATA POLLEN;
  • 6 [hp_X]/mL FAGUS GRANDIFOLIA POLLEN;
  • 6 [hp_X]/mL FRAXINUS AMERICANA POLLEN;
  • 6 [hp_X]/mL JUGLANS NIGRA POLLEN;
  • 12 [hp_X]/mL LYCOPODIUM CLAVATUM SPORE;
  • 6 [hp_X]/mL MELALEUCA ALTERNIFOLIA FLOWERING TOP;
  • 6 [hp_X]/mL PLATANUS OCCIDENTALIS POLLEN;
  • 6 [hp_X]/mL POPULUS DELTOIDES SUBSP. DELTOIDES POLLEN;
  • 12 [hp_X]/mL PULSATILLA VULGARIS;
  • 6 [hp_X]/mL QUERCUS RUBRA POLLEN;
  • 6 [hp_X]/mL SALIX NIGRA POLLEN;
  • 6 [hp_X]/mL ULMUS AMERICANA POLLEN


Administration Route(s): ORAL

Dosage Form(s): LIQUID

Pharmacy Class(es):
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Increased Histamine Release [PE];
  • Increased Histamine Release [PE];
  • Increased Histamine Release [PE];
  • Increased Histamine Release [PE];
  • Increased Histamine Release [PE];
  • Increased Histamine Release [PE];
  • Increased Histamine Release [PE];
  • Increased Histamine Release [PE];
  • Increased Histamine Release [PE];
  • Increased Histamine Release [PE];
  • Increased IgG Production [PE];
  • Increased IgG Production [PE];
  • Increased IgG Production [PE];
  • Increased IgG Production [PE];
  • Increased IgG Production [PE];
  • Increased IgG Production [PE];
  • Increased IgG Production [PE];
  • Increased IgG Production [PE];
  • Increased IgG Production [PE];
  • Increased IgG Production [PE];
  • Non-Standardized Pollen Allergenic Extract [EPC];
  • Non-Standardized Pollen Allergenic Extract [EPC];
  • Non-Standardized Pollen Allergenic Extract [EPC];
  • Non-Standardized Pollen Allergenic Extract [EPC];
  • Non-Standardized Pollen Allergenic Extract [EPC];
  • Non-Standardized Pollen Allergenic Extract [EPC];
  • Non-Standardized Pollen Allergenic Extract [EPC];
  • Non-Standardized Pollen Allergenic Extract [EPC];
  • Non-Standardized Pollen Allergenic Extract [EPC];
  • Non-Standardized Pollen Allergenic Extract [EPC];
  • Pollen [CS];
  • Pollen [CS];
  • Pollen [CS];
  • Pollen [CS];
  • Pollen [CS];
  • Pollen [CS];
  • Pollen [CS];
  • Pollen [CS];
  • Pollen [CS];
  • Pollen [CS]

Labeler Information

Labeler Name: BioActive Nutritional, Inc.
Product Type: HUMAN OTC DRUG
FDA Application Number:
Marketing Category: UNAPPROVED HOMEOPATHIC
Start Marketing Date:8/7/2013
End Marketing Date:2/18/2024

Package Information

No. Package Code Package Description Billing Unit
143857-0173-130 mL in 1 BOTTLE, DROPPER (43857-0173-1)

NDC Record

Field Name Field Value Definition
PRODUCT NDC43857-0173The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN OTC DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMETREE ANTIGENThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAMEAmerican Beech, American Elm, Black Walnut, Black Willow, Negundo, Eastern Cottonwood, Hickory, Red Birch, Red Oak, Platanus, Fraxinus Americana, Melaleuca Blossom, Arsenicum Album, Lycopodium Clavatum, Pulsatilla VulgarisThe non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMELIQUIDThe translation of the dosage form Code submitted by the firm.
ROUTE NAMEORALThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE8/7/2013This is the date that the labeler indicates was the start of its marketing of the drug product.
END MARKETING DATE2/18/2024This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
MARKETING CATEGORY NAMEUNAPPROVED HOMEOPATHICProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMEBioActive Nutritional, Inc.Name of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMEACER NEGUNDO POLLEN; ARSENIC TRIOXIDE; BETULA OCCIDENTALIS POLLEN; CARYA OVATA POLLEN; FAGUS GRANDIFOLIA POLLEN; FRAXINUS AMERICANA POLLEN; JUGLANS NIGRA POLLEN; LYCOPODIUM CLAVATUM SPORE; MELALEUCA ALTERNIFOLIA FLOWERING TOP; PLATANUS OCCIDENTALIS POLLEN; POPULUS DELTOIDES SUBSP. DELTOIDES POLLEN; PULSATILLA VULGARIS; QUERCUS RUBRA POLLEN; SALIX NIGRA POLLEN; ULMUS AMERICANA POLLENAn active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH6; 12; 6; 6; 6; 6; 6; 12; 6; 6; 6; 12; 6; 6; 6 
ACTIVE INGRED UNIT[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL 
PHARM CLASSESAllergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS], Pollen [CS] 

Download Record

Download this NDC record in Text format: Export

Download this NDC record in Excel (CSV) format: Export

Download this NDC record in XML format: Export

This page was last updated on: 2/1/2023